CKD Bio Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for CKD Bio.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 33.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 Sep 2024 |
Recent future growth updates
No updates
Recent updates
What You Need To Know About CKD Bio Corp.'s (KRX:063160) Investor Composition
Feb 28
Is CKD Bio's (KRX:063160) 203% Share Price Increase Well Justified?
Feb 01
CKD Bio (KRX:063160) Takes On Some Risk With Its Use Of Debt
Jan 11What CKD Bio Corp.'s (KRX:063160) ROE Can Tell Us
Dec 21Here's Why We Don't Think CKD Bio's (KRX:063160) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 194,500 | N/A | N/A | N/A | 1 |
| 9/30/2023 | 159,935 | -23,130 | -25,355 | -16,588 | N/A |
| 6/30/2023 | 155,183 | -20,233 | -20,483 | -11,038 | N/A |
| 3/31/2023 | 152,876 | -18,403 | -15,290 | -8,075 | N/A |
| 12/31/2022 | 156,042 | -16,703 | -10,435 | -3,205 | N/A |
| 9/30/2022 | 154,395 | -10,462 | -6,837 | 1,239 | N/A |
| 6/30/2022 | 154,759 | -11,222 | -10,230 | 721 | N/A |
| 3/31/2022 | 155,569 | -5,821 | -15,703 | -436 | N/A |
| 12/31/2021 | 142,238 | -6,577 | -26,588 | -5,882 | N/A |
| 9/30/2021 | 135,760 | -6,730 | -30,532 | -7,506 | N/A |
| 6/30/2021 | 130,483 | -1,111 | -40,416 | -6,503 | N/A |
| 3/31/2021 | 127,741 | 1,771 | -52,783 | -3,114 | N/A |
| 12/31/2020 | 124,600 | 6,207 | -57,785 | 4,824 | N/A |
| 9/30/2020 | 135,773 | 10,664 | -61,903 | 6,278 | N/A |
| 6/30/2020 | 138,042 | 12,633 | -56,651 | 10,401 | N/A |
| 3/31/2020 | 136,265 | 12,446 | -36,094 | 19,449 | N/A |
| 12/31/2019 | 137,184 | 12,265 | -30,817 | 16,990 | N/A |
| 9/30/2019 | 129,529 | 10,563 | -27,627 | 19,152 | N/A |
| 6/30/2019 | 127,134 | 9,605 | -13,990 | 19,668 | N/A |
| 12/31/2018 | 124,510 | 7,956 | -1,477 | 15,536 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A063160's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A063160's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A063160's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A063160's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A063160's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A063160's Return on Equity is forecast to be high in 3 years time